NEW YORK, Sept. 13, 2016 /PRNewswire/ -- Medivo, Inc., a
leader in clinical diagnostic analytics, will host a roundtable
session as well as address the entire audience at the PharmaForce
Annual Conference, which is being held September 12-14, 2016 at The Westin Princeton at
Forrestal Village in Princeton, New
Jersey.
The sessions will be led by Jason
Bhan, MD, Medivo's Chief Medical Officer and Co-Founder, and
focus on the importance of clinical diagnostics in reacting to the
opportunities and challenges facing pharma brands and drugs in the
pipeline, and the value of clinical diagnostics in precision
medicine. Dr. Bhan will explore challenges related to the
latest evolutions in the pharma commercial market, such as
increasing healthcare costs, new commercial models, and small
markets.
Medivo's CLEAR Insights allow brand marketers to develop
intelligent physician profiling and early insights based on data
from Medivo's nationwide network of partner labs, which offers
access to over 150 million patients. Lab data is critical as
it influences 70% or more of medical decisions and can be delivered
within a few days of testing, making it available well before the
treatment decisions are made.
"Clinical diagnostics data provides insights that other data
sources cannot," said Dr. Bhan. "As a physician, this information
is invaluable in choosing the best course of treatment for a
patient. The same is true for pharma brands in recommending
their therapies."
"Medivo's clinical diagnostic solutions provide fast and
actionable insights that allow Life Science Brand marketers to find
the right patients based on specific biomarkers," adds Anne Bentley, Chief Marketing Officer at
Medivo. "Because our solutions allow pharma brands to
influence treatment decisions before they are made, they contribute
immensely to brand success."
Medivo will exhibit at the PharmaForce conference at booth #2,
and will host their keynote address and roundtable sessions
entitled "Addressing Pharma Brand Challenges with Clinical
Diagnostics" on Tuesday, September 13th. Attendees hoping to
connect with Medivo at the conference can submit their contact
information at the following web address:
http://info.medivo.com/pharmaforce2016.
About Medivo
Medivo is a healthcare analytics company that unlocks the power
of clinical diagnostic data to improve health. Medivo is the
largest source of clinical diagnostic data in the U.S., with access
to over 150 million patients and 4 billion lab records through its
nationwide network of partner labs. Medivo has over six years
experience in developing proprietary clinical algorithms and
deploying advanced analytics solutions for healthcare companies to
improve targeting, commercial effectiveness, quality improvement
and risk management. Founded in 2010, Medivo's investors
include Safeguard Scientifics, Inc. (NYSE:SFE) and Merck Global
Health Innovation Fund (GHIF). For more information, visit
http://www.medivo.com.
Logo - http://photos.prnewswire.com/prnh/20151102/282959LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/medivo-to-introduce-the-results-of-using-clinical-diagnostics-based-artificial-intelligence-to-predict-disease-300327069.html
SOURCE Medivo, Inc.